Viking Therapeutics (VKTX) stock gains as Roche (RHHBY) and Zealand Pharma's (ZLDPF) $5.3B deal for obesity drugs lifts ...

Anterior cruciate ligament (ACL) injuries are prevalent, with over 400 000 reconstruction surgeries globally each year.

Roche is doubling down on competing for a slice of the rapidly growing GLP-1 pie. The Swiss pharma giant announced a deal worth up to $5.3 billion on Wednesday with Danish drugmaker Zealand Pharma to ...

Galcanezumab provided greater reductions in migraine frequency, resulting in a shift from chronic to episodic migraine over a 12-month period compared with placebo.

Novo Nordisk (NVO) released clinical trial results for its potential Ozempic successor on Monday, disappointing Wall Street ...

People assigned female at birth have a predisposition for migraines, especially in adolescence and around menopause. Find a ...

Novo Nordisk has reported the second phase 3 trial of its new obesity hopeful CagriSema but, as with the first, the topline ...

It's not too often that pharmaceutical drugs become household names, but that's happening with medicines in the weight loss ...

It is specifically designed to bind to and activate amylin and calcitonin receptors, both of which play roles in regulating aspects of metabolism, such as appetite. The once-weekly injectable drug ...

Roche and Zealand Pharma inked a $5.3 billion deal Wednesday to collaborate on a weight-loss drug in the amylin class.

Saskia Clark, 24, has been documenting her cancer journey via her TikTok channel under the name @saskiaclrk. She recently opened up about her symptoms and diagnosis ...

In a partnership marking AbbVie’s entrance into the weight management field, the US pharma major has signed a licensing deal ...